Increased Leukotriene E 4 in the Exhaled Breath Condensate of Children With Mild Asthma*
|
|
- Samson Sparks
- 6 years ago
- Views:
Transcription
1 CHEST Original Research Increased Leukotriene E 4 in the Exhaled Breath Condensate of Children With Mild Asthma* Atsushi Shibata, MD; Toshio Katsunuma, MD, PhD; Morimitsu Tomikawa, MD; Aiko Tan, MD; Keisuke Yuki, PhD; Kenichi Akashi, MD; and Yoshikatsu Eto, MD, PhD ASTHMA Background: Chronic airway inflammation is a feature of asthma. Increased levels of cysteinyl leukotrienes (cys-lts; leukotriene [LT]C 4, LTD 4, LTE 4 ) have been shown in the exhaled breath condensate (EBC) of children with moderate-to-severe asthma. The aim of this study was to examine the relationship between EBC cys-lts (LTE 4 ) levels and bronchial hyperreactivity in children with mild asthma in order to evaluate the clinical utility of measuring EBC cys-lts levels. Methods: We measured LTE 4 levels in the EBC of children aged 8 to 18 years, including healthy nonasthmatic children (n 6) and children with mild asthma (n 37). Patients with mild asthma were classified into the following three groups: group 1, participants who had been asymptomatic (no wheezing/symptoms of asthma) for > 6 months prior to examination (n 12); group 2, participants who were asymptomatic but had had wheezing/symptoms of asthma within 6 months before examination (n 18); and group 3, patients with current wheeze and/or mild symptoms of asthma exacerbation at the time of examination. Results: Exhaled LTE 4 levels were increased in all children with mild asthma compared with nonasthmatic control subjects ( pg/20 min vs pg/20 min, p < 0.05) [mean SD]. In particular, the EBC LTE 4 levels in group 2 ( pg/20 min) and group 3 ( pg/20 min) were increased compared with control subjects and group 1 ( pg/20 min). The EBC LTE 4 levels negatively correlated with the provocative concentration of methacholine causing a 15% fall in FEV 1 (r 0.454, p 0.012). Conclusion: EBC cys-lts may be useful as a noninvasive marker assessing airway inflammation and hyperreactivity in children with asthma. (CHEST 2006; 130: ) Key words: childhood asthma; exhaled breath condensate; leukotriene E 4 ; mild asthma Abbreviations: cys-lt cysteinyl leukotriene; EBC exhaled breath concentrate; eno exhaled nitric oxide; LT leukotriene; PC 15 provocative concentration of methacholine causing a 15% fall in FEV 1 Asthma is characterized by chronic airway inflammation that is evident even in patients with mild disease. 1 Several studies 2 6 describing biopsy patterns of inflammation in children with asthma have been published in the last few years. The safety of the endobronchial biopsy procedure has also been *From the Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan. The authors have no financial or other potential conflicts of interest associated with this study. Manuscript received September 23, 2005; revision accepted June 28, documented. 7 In addition, the measurement of levels of exhaled nitric oxide (eno), reflecting the activity of airway eosinophil, mast cells, and epithelial cells, has been found to be easy, noninvasive, and useful in asthmatic patients Reproduction of this article is prohibited without written permission from the American College of Chest Physicians ( org/misc/reprints.shtml). Correspondence to: Toshio Katsunuma, MD, PhD, Department of Pediatrics, The Jikei University School of Medicine, , Nishi-Shinbashi, Minato-ku, Tokyo, , Japan; tkatsunuma@jikei.ac.jp DOI: /chest Original Research
2 Performing bronchoscopy-guided biopsy, however, is still likely to be difficult in children, at least as a common clinical diagnostic tool. Moreover, elevated eno levels are not specific for asthma, given that increased eno is found in other inflammatory respiratory disorders, such as sinus disease and viral upper respiratory tract infection. 11,12 Increased levels of cysteinyl leukotrienes (cys- LTs) have been detected in the exhaled breath condensate (EBC) of children with moderate-tosevere persistent asthma. 13,14 The measurement of cys-lts in the EBC may be useful as a noninvasive way to assess airway inflammation. Bronchial hyperresponsiveness to methacholine, histamine, or exercise is a key feature of asthma, and may be an indicator of asthma severity. Bronchial hyperreactivity relates closely to asthma severity of asthma and frequency of symptoms, as well as to need for treatment. 15 The aim of the present study was to examine the relationship between leukotriene (LT) E 4 levels and bronchial hyperreactivity in mild asthma in children. Such a correlation would allow us to evaluate the clinical utility of measuring EBC cys-lts levels as a marker of airway inflammation in childhood asthma. Finally, we hope to apply the results to the diagnosis of asthma in infants and children 6 years old, in whom the correct diagnosis of asthma is not easy. Patients Materials and Methods Children (age range, 8 to 18 years) with asthma were recruited from the pediatric clinic of the Jikei University Hospital, Tokyo, Japan. We measured EBC and urinary LTE 4 levels of all participants, including healthy nonasthmatic children (n 6) and children with mild asthma (n 37). Eosinophil counts and serum IgE were determined from the blood samples collected from the asthmatic children. Patients with mild asthma were classified into three groups: group 1, subjects who had been asymptomatic (no wheezing/ symptoms of asthma) for 6 months prior to examination (n 12); group 2, subjects who were asymptomatic but had had wheezing/symptoms of asthma within 6 months before examination (n 18); and group 3, subjects with current wheeze and/or mild symptoms of asthma exacerbation at the time of examination (n 7). EBC collection could be performed in group 3 members because their dyspnea was not severe. However, the methacholine provocation test was not performed to prevent inducing serious bronchoconstriction. Patient characteristics are summarized in Table 1. There was no significant difference in age between the groups. The number of subjects treated with fluticasone propionate is also summarized in Table 1. No child had been treated with a dose 200 g/d (mean daily dose in group 1, g; group 2, g; group 3: g). No patient was taking aspirin before or during EBC collection. The diagnosis of bronchial asthma was based on the criteria of the American Thoracic Society, 16 and asthma severity was classified according to the Global Initiative for Asthma guidelines. 17 When severity was based on clinical features present and the step of the daily medication with fluticasone ( 200 g/d), all the subjects were considered to have mild intermittent or persistent asthma. Healthy nonasthmatic control children were recruited from among the children of one of the authors (T.K.) and his friends. It was confirmed by the parent(s), using a questionnaire regarding medical history, that the children in the control group had no history wheezing episode or of allergic disease. The protocol was approved by the Ethics Committee of the Jikei University, and informed consent was obtained from all parents and children recruited into the study. Study Design Baseline spirometry followed by collection of EBC and bronchial responsiveness to methacholine were measured. All medications were withheld for at least 12 h, and montelukast and salmeterol were withheld for 36 h before testing. Measurements of Provocative Concentration of Methacholine Causing a 15% Fall in FEV 1 Spirometry (Autospiro AS500; Minato; Osaka, Japan) was performed using standard techniques. Aerosol was delivered using a nebulizer (model 646; Devilbis; Somerset, PA). Subjects Table 1 Patient Characteristics* Characteristics Control Group (n 6) Group 1, No Wheeze 6mo (n 12) Group 2, Wheeze 6mo (n 18) Group 3, Mild Exacerbation (n 7) Age, yr 10.3 (9 12) 10.9 (8 16) 12.2 (8 18) 10.2 (8 14) Male/female gender, No. 5/1 11/1 14/4 5/2 PEFR, % predicted 94.3 (32 132) 98.0 (70 112) (70 137) 97.6 (79 120) FEV 1, % predicted 91.3 (82 108) 94.8 (82 111) 90.6 (79 106) 82.4 (58 116) FEV 1 /FVC 89.6 (85 92) 84.5 (76 91) 83.3 (73 91) 83.1 (59 89) MMF, % predicted 91.3 (70 115) 88.4 (66 118) 72.3 (51 99) 65.7 (26 91) Eosinophil, % Not done 9.8 ( ) 7.8 ( ) 5.3 ( ) Total IgE, IU/mL Not done 2,018 (64 14,674) 1,414 ( ) 676 (33 1,816) FP, yes/no 0/6 9/3 11/7 6/1 LT1RA, yes/no 0/6 4/8 10/8 5/2 *Data are presented as mean (range) unless otherwise indicated. PEFR peak expiratory flow rate; MMF maximum midexpiratory flow rate; FP fluticasone propionate; LT1RA cys-lt1 receptor antagonist. CHEST / 130 / 6/ DECEMBER,
3 inhaled normal saline solution at first as a control. Then increasing doses of methacholine, starting from mg/ml and then progressively doubling the concentration to reach 16 mg/ml, were administered. The provocative concentration of methacholine causing a 15% fall in FEV 1 (PC 15 ) was calculated. EBC EBC was collected by using a handcrafted condenser constructed as per a report by Scheideler et al. 18 The validity of measuring LT levels in EBC using our handcrafted condenser was confirmed by the Bland-Altman plot in comparison with Ecoscreen (Jaeger; Hoechberg, Germany). 19 Amylase in the EBC was measured by the 2-chloro-4-nitrophenyl maltotrioside method (Kanto Chemical; Tokyo, Japan), with a lower limit of detection of 1.4 IU/L. Amylase was not detected in the EBC samples. Subjects were asked to breathe through a mouthpiece at a normal frequency and tidal volume for a period of 20 min with a nose clip. Condensate of least 1 ml in volume was collected and immediately stored at 80 C. The mean collected volume of EBC was 4.5 ml. LT Measurement The samples were freeze-dried with a freeze-drier (EYELA FDU-2200; Tokyo Rika Kikai; Tokyo, Japan). After freeze-drying, the samples were resolved with 100 L of water, and LTE 4 concentrations were measured with a specific enzyme immunoassay (Cayman Chemical; Ann Arbor, MI). We initially concentrated the EBC samples by freeze-drying in order to improve the sensitivity for detection of LTE 4 concentrations. The lower limit of detection was 30 pg/ml. LTE 4 values in EBC were expressed as the total amount (in picograms) expired in 20 min of breath. 20 to 2.2 pg/20 min; p 0.05) [Fig 1]. In particular, EBC LTE 4 levels in group 2 ( pg/20 min; range, 0.49 to 28.7 pg/20 min) and in group 3 ( pg/20 min; range, 0.41 to 49.4 pg/20 min) were increased compared with control subjects and with group 1 ( pg/20 min; range, 0.17 to 6.4 pg/20 min). There were no significant differences in urinary LTE 4 levels among the groups (control subjects, 2,610 2,326 pg/mg creatinine; group 1, 1,523 2,140 pg/mg creatinine; group 2, 982 1,628 pg/mg creatinine; group 3, 1,679 1,105 pg/mg creatinine) [Fig 2]. EBC LTE 4 levels were negatively correlated with PC 15 (r 0.454, p 0.012) [Fig 3]. Among group 1 members, EBC LTE 4 levels were significantly lower (p 0.05) and PC 15 levels were significantly higher (p 0.05) than in group 2 members. Discussion We found a significant increase in EBC LTE 4 concentrations in children with mild asthma. In group 2 (those who were asymptomatic but had had wheezing/symptoms of asthma within 6 months prior to examination) and in group 3 (children with current wheeze and/or mild symptoms of asthma exacerbation at the time of examination), EBC LTE 4 levels were significantly increased compared with control subjects or group 1 (children who had been asymptomatic for 6 months prior to the examina- Statistical Analysis Statistical analysis was performed using the statistical software (SAS version 8.2; SAS Institute; Cary, NC). A Student t test was used to confirm the difference between the control and mild asthma groups for the primary end point of this study. After confirmation of the primary end point, a Tukey multiple comparison tests was used to compare the mean values between control and each asthma groups. Data were expressed as mean SD. The correlation between the LTE 4 levels and the PC 15 was determined by nonparametric Spearman correlation analysis. Statistical significance was defined at p Results There were no significant differences among the groups in serum IgE levels or peripheral blood eosinophil counts (Table 1). All the subjects in groups 1 to 3 were atopic, as confirmed by positive levels of serum IgE to at least one of the following antigens: house dust mite, Japanese cedar pollen, or cat dander. EBC LTE 4 levels, however, were increased in all patients with mild asthma ( pg/20 min; range, 0.41 to 49.4 pg/20 min) vs nonasthmatic control subjects ( pg/20 min; range, 0.31 Figure 1. Exhaled LTE 4 levels in children with mild asthma. Exhaled LTE 4 levels were increased in all patients with mild asthma compared with nonasthmatic control (cont) subjects. EBC LTE 4 levels in group 2 patients (children who were asymptomatic but had had wheezing/symptoms of asthma within 6 months before examination) and group 3 (children with current wheeze and mild symptoms of asthma at the time of examination) were increased compared with control subjects and with group 1 patients (children who had been asymptomatic, with no wheezing/symptoms of asthma, for 6 months prior to examination). *p 0.05; p 0.05 (vs group 1 patients) Original Research
4 Figure 2. Urinary LTE 4 levels. There were no significant differences in urinary (U) LTE 4 levels among the groups. Cr creatinine. See Figure 1 for expansion of abbreviation. tion), suggesting that EBC LTE 4 levels may reflect a clinical instability of asthmatic symptoms based on the latent activity of airway inflammation. Csoma et al 21 found that the concentrations of EBC cys-lts of asymptomatic children with mild intermittent asthma were not significantly elevated compared to normal subjects, even though EBC cys-lts of patients with mild persistent, and moderate-to-severe persistent asthma were elevated. One probable explanation for this difference between those results and ours is that Csoma et al 21 might have primarily studied patients with mild intermittent asthma and very stable symptoms. In this study, we could not find a significant difference in the EBC LTE 4 levels of nonasthmatic control subjects and patients with mild asthma who had been asymptomatic for 6 months prior to examination. We also found a significant correlation between EBC LTE 4 levels and PC 15 in our subjects (r 0.454, p 0.012) [Fig 3]. It is known that Figure 3. EBC LTE 4 levels were negatively correlated with methacholine (r 0.454, p 0.012). airway hyperresponsiveness is a key feature of asthma and can be used as an indicator of asthma severity. This correlation suggests that LT itself may contribute to airway hyperresponsiveness. 22 A few previous studies 23,24 have reported no correlation between the activation of airway inflammatory cells, such as eosinophils and mast cells, and the degree of airway hyperresponsiveness in asthmatic subjects; however, there are also a similar number of studies that do show a significant correlation. Our result, depicting a significant correlation between EBC LTE 4 levels and airway hyperreactivity, suggests that airway hyperreactivity is affected by the extent of airway inflammation. Measurement of EBC LTE 4 can be a marker reflecting airway inflammation and hyperreactivity, which may be useful in infants and young children in whom the objective estimation of asthma can be difficult to perform. However, further longitudinal study must be necessary to more thoroughly investigate the clinical utility of EBC LTs. Cys-LTs are mainly produced by airway mast cells and eosinophils. In this study, we could not determine the exact source of the cys-lts because there were no significant differences in serum IgE levels and in peripheral eosinophil counts among the groups. This would imply that the function of mast cells and/or eosinophils, rather than the actual number of cells, may more greatly affect EBC LTE 4 levels. Some of the subjects had been treated with inhaled fluticasone propionate ( 200 g/d in all users) prior to examination (Table 1). There were no significant differences in frequency of fluticasone users between group 1 and group 2. However, the frequency in group 3 was significantly higher than group 1 and group 2. Mondino et al 13 showed that EBC LTE 4 levels in children with asthma were reduced by 18% after 4 weeks of treatment with fluticasone. Nevertheless, we found that EBC LTE 4 levels in group 3 were increased, not decreased, compared with control subjects and group 1. Therefore, although the higher number of children treated with fluticasone in group 3 might have affected the results, we would predict the effect of fluticasone to be the opposite of what our results show. In fact, we may have found even higher levels of LTE 4 if fewer children in group 3 had been treated with fluticasone. Our results suggest that airway cys-lts may play a role in the pathogenesis of asthma even in children with mild, asymptomatic asthma, and that levels of airway cys-lts may reflect degree of airway hyperreactivity, probably based on chronic airway inflammation. Given these perspectives, the current asthma treatment recommendations, as stated in CHEST / 130 / 6/ DECEMBER,
5 many guidelines, that suggest early intervention with inhaled corticosteroid seem reasonable. EBC cys-lts may be useful as a noninvasive marker assessing airway inflammation and hyperreactivity in children with asthma. In the future, we would expect that measuring EBC LTs will become a part of the clinical practice in asthma management in combination with other useful markers such as eno, especially in infants and young children. References 1 Synek M, Beasley R, Holgate ST, et al. Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med 1996; 154: Barbato A, Turato G, Baraldo S, et al. Airway inflammation in childhood asthma. Am J Respir Crit Care Med 2003; 168: Van Den Toorn LM, Overbeek SE, Prins JB, et al. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001; 164: Cokugras H, Akcakaya N, Aksoy F, et al. Ultrastructural examination of bronchial biopsy specimens from children with moderate asthma. Thorax 2001; 56: Payne DNR, Qiu Y, Jeffery PK, et al. Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms. Thorax 2004; 59: Payne DNR, Rogers AV, Jeffery PK, et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003; 167: Salva PS, Theroux C, Schwartz D. Safety of ronchial biopsy in 170 children with chronic respiratory symptoms. Thorax 2003; 58: Jatakanon A, Lim S, Barnes PJ, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53: Lim S, Jatakanon A, Barnes PJ, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma. Thorax 2000; 55: Strunk RC, Szefler SJ, Lemanske RF Jr, et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003; 112: Al-Ali MK, Howarth PH. Nitric oxide and the respiratory system in health and disease. Respir Med 1998; 92: Kharitonov SA, Yates D, Barnes PJ. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995; 8: Mondino C, Ciabattoni G, Koch P, et al. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children: exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 2004; 114: Zanconato S, Carraro S, Baraldi E, et al. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol 2004; 113: Juniper EF, Frith PA, Hargreave FE. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 1981; 36: American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: Global Initiative for Asthma. Workshop Report, global strategy for asthma management and prevention. Available at: 2&/2 1& intid 60. Accessed August 1, Scheideler L, Manke HG, Hammerle H, et al. Detection of nonvolatile macromolecules in breath: a possible diagnostic tool? Am Rev Respir Dis 1993; 148: Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Method Med Res 1999; 8: Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 2002; 109: Csoma Z, Kharitonov SA, Barnes PJ, et al. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002; 166: Leff AR. Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Thorax 2000; 55(suppl2):S32 S37 23 Ollerenshaw SL, Woolcock AJ. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. Am Rev Respir Dis 1992; 145: Crimi E, Spanevello A, Brusasco V, et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998; 157: Jeffery PK, Wardlaw AJ, Kay AB, et al. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989; 140: Kelly C, Ward C, Walters EH, et al. Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway responsiveness. Thorax 1988; 43: Laprise C, Laviolette M, Boulet LP, et al. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur Respir J 1999; 14: Chetta A, Foresi A, Olivieri D, et al. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma. Am J Respir Crit Care Med 1996; 153: Warner JO, Marguet C, Pohunek P, et al. Inflammatory mechanisms in childhood asthma. Clin Exp Allergy 1998; 28:S71 S75 30 Martinez FD. Present and future treatment of asthma in infants and young children. J Allergy Clin Immunol 1999; 104:S169 S Spahn JD, Szefler SJ. Childhood asthma: new insights into management. J Allergy Clin Immunol 2002; 109: Original Research
Adenosine 5 0 -monophosphate increases levels of leukotrienes in breath condensate in asthma
Respiratory Medicine (2004) 98, 651 655 Adenosine 5 0 -monophosphate increases levels of leukotrienes in breath condensate in asthma E. Bucchioni, Z. Csoma, L. Allegra, K.F. Chung, P.J. Barnes, S.A. Kharitonov*
More informationExhaled Nitric Oxide: An Adjunctive Tool in the Diagnosis and Management of Asthma
Exhaled Nitric Oxide: An Adjunctive Tool in the Diagnosis and Management of Asthma Jason Debley, MD, MPH Assistant Professor, Pediatrics Division of Pulmonary Medicine University of Washington School of
More informationUsing Patient Characteristics to Individualize and Improve Asthma Care
Using Patient Characteristics to Individualize and Improve Asthma Care Leonard B. Bacharier, M.D. Associate Professor of Pediatrics Clinical Director, Division of Allergy, Immunology, & Pulmonary Medicine
More informationChronic Cough Due to Nonasthmatic Eosinophilic Bronchitis. ACCP Evidence-Based Clinical Practice Guidelines
Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis ACCP Evidence-Based Clinical Practice Guidelines Christopher E. Brightling, MBBS, PhD, FCCP Objectives: Nonasthmatic eosinophilic bronchitis is
More informationAllergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al.
Allergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al. Chapter 75: Approach to Infants and Children with Asthma
More informationLife-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton
Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary
More informationEffects of a leukotriene receptor antagonist on exhaled leukotriene E 4 and prostanoids in children with asthma
Effects of a leukotriene receptor antagonist on exhaled leukotriene E 4 and prostanoids in children with asthma Paolo Montuschi, MD, a Chiara Mondino, MD, b Pierluigi Koch, MD, c Peter J. Barnes, DM, d
More informationImpact of Asthma in the U.S. per Year. Asthma Epidemiology and Pathophysiology. Risk Factors for Asthma. Childhood Asthma Costs of Asthma
American Association for Respiratory Care Asthma Educator Certification Prep Course Asthma Epidemiology and Pathophysiology Robert C. Cohn, MD, FAARC MetroHealth Medical Center Cleveland, OH Impact of
More informationClinical trial efficacy: What does it really tell you?
Clinical trial efficacy: What does it really tell you? Joseph Spahn, MD Denver, Colo The primary goal of most clinical trials is an evaluation of the efficacy of the drug being evaluated. Therefore, it
More information8-ISOPROSTANE IN NASALLY EXHALED BREATH CONDENSATE IN DIFFERENT PEDIATRIC LUNG DISEASES
January 31, 2007 EU RO PE AN JOUR NAL OF MED I CAL RE SEARCH 21 Eur J Med Res (2007) 12: 21-25 I. Holzapfel Publishers 2007 8-ISOPROSTANE IN NASALLY EXHALED BREATH CONDENSATE IN DIFFERENT PEDIATRIC LUNG
More informationPeak Expiratory Flow Variability Adjusted by Forced Expiratory Volume in One Second is a Good Index for Airway Responsiveness in Asthmatics
ORIGINAL ARTICLE Peak Expiratory Flow Variability Adjusted by Forced Expiratory Volume in One Second is a Good Index for Airway Responsiveness in Asthmatics Kazuto Matsunaga, Masae Kanda, Atsushi Hayata,
More informationDo current treatment protocols adequately prevent airway remodeling in children with mild intermittent asthma?
Respiratory Medicine (2006) 100, 458 462 Do current treatment protocols adequately prevent airway remodeling in children with mild intermittent asthma? Haim S. Bibi a,, David Feigenbaum a, Mariana Hessen
More informationCombined use of exhaled nitric oxide and airway hyperresponsiveness in characterizing asthma in a large population survey
Eur Respir J 2000; 15: 849±855 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2000 European Respiratory Journal ISSN 0903-1936 Combined use of exhaled nitric oxide and airway hyperresponsiveness
More informationNG80. Asthma: diagnosis, monitoring and chronic asthma management (NG80)
Asthma: diagnosis, monitoring and chronic asthma management (NG80) NG80 NICE has checked the use of its content in this product and the sponsor has had no influence on the content of this booklet. NICE
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: exhaled_nitric_oxide_measurement 2/2009 3/2018 3/2019 3/2018 Description of Procedure or Service Asthma is
More informationMeasurement of Exhaled Breath Condensate in the Diagnosis and Management of Respiratory Disorders
Medical Policy Manual Medicine, Policy No. 108 Measurement of Exhaled Breath Condensate in the Diagnosis and Management of Respiratory Disorders Next Review: January 2019 Last Review: January 2018 Effective:
More informationYoung Yoo, MD; Jinho Yu, MD; Do Kyun Kim, MD; and Young Yull Koh, MD
Original Research ASTHMA Percentage Fall in FVC at the Provocative Concentration of Methacholine Causing a 20% Fall in FEV 1 in Symptomatic Asthma and Clinical Remission During Adolescence* Young Yoo,
More informationDistinction and Overlap. Allergy Dpt, 2 nd Pediatric Clinic, University of Athens
Asthma Phenotypes: Distinction and Overlap Nikos Papadopoulos Allergy Dpt, 2 nd Pediatric Clinic, University of Athens Asthma as a syndrome From the Iliad to ADAM 33 and back again Bronchoconstriction,
More informationCurrent Asthma Management: Opportunities for a Nutrition-Based Intervention
Current Asthma Management: Opportunities for a Nutrition-Based Intervention Stanley J. Szefler, MD Approximately 22 million Americans, including 6 million children, have asthma. It is one of the most prevalent
More informationEffects of inhaled versus systemic corticosteroids on exhaled nitric oxide in severe acute asthma
Respiratory Medicine (2009) 103, 614e620 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Effects of inhaled versus systemic corticosteroids on exhaled nitric oxide in
More informationClinical efficacy of montelukast in anti-inflammatory treatment of asthma and allergic rhinitis
Clinical efficacy of montelukast in anti-inflammatory treatment of asthma and allergic rhinitis Kim Hyun Hee, MD, PhD. Dept. of Pediatrics The Catholic University of Korea College of Medicine Achieving
More informationA diagnosis of asthma is made on the basis of compatible
383 ASTHMA Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests N Berkman, A Avital, R Breuer, E Bardach, C Springer, S Godfrey... See end of article for authors
More informationElevated nitrite in breath condensates of children with respiratory disease
Eur Respir J 2002; 19: 487 491 DOI: 10.1183/09031936.02.00101202 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2002 European Respiratory Journal ISSN 0903-1936 Elevated nitrite in breath
More informationThe natural history of asthma and early intervention
The natural history of asthma and early intervention Stanley J. Szefler, MD Denver, Colo The understanding of the natural history of asthma has changed significantly during the last 4 decades, with the
More informationOptimal Assessment of Asthma Control in Clinical Practice: Is there a role for biomarkers?
Disclosures: Optimal Assessment of Asthma Control in Clinical Practice: Is there a role for biomarkers? Stanley Fineman, MD Past-President, American College of Allergy, Asthma & Immunology Adjunct Associate
More informationImportance of fractional exhaled nitric oxide in diagnosis of bronchiectasis accompanied with bronchial asthma
Original Article Importance of fractional exhaled nitric oxide in diagnosis of bronchiectasis accompanied with bronchial asthma Feng-Jia Chen, Huai Liao, Xin-Yan Huang, Can-Mao Xie Department of Respiratory
More informationPathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma
Allergy 2001: 56: Suppl. 66: 7 11 Printed in UK. All rights reserved Copyright # Munksgaard 2001 ALLERGY ISSN 0108-1675 Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor
More informationAsthma Management for the Athlete
Asthma Management for the Athlete Khanh Lai, MD Assistant Professor Division of Pediatric Pulmonary and Sleep Medicine University of Utah School of Medicine 2 nd Annual Sports Medicine Symposium: The Pediatric
More informationManagement of asthma in preschool children with inhaled corticosteroids and leukotriene receptor antagonists Leonard B. Bacharier
Management of asthma in preschool children with inhaled corticosteroids and leukotriene receptor antagonists Leonard B. Bacharier Department of Pediatrics, Division of Allergy and Pulmonary Medicine, Washington
More informationALLERGIC RHINITIS AND ASTHMA :
ALLERGIC RHINITIS AND ASTHMA : from the Link to Emerging Therapies Allergic rhinitis and asthma are both chronic heterogeneous disorders, with an overlapping epidemiology of prevalence, health care costs
More informationAirway Inflammation in Asthma Chih-Yung Chiu 1,2, Kin-Sun Wong 2 1 Department of Pediatrics, Chang Gung Memorial Hospital, Keelung, Taiwan.
REVIEW ARTICLE Chih-Yung Chiu 1,2, Kin-Sun Wong 2 1 Department of Pediatrics, Chang Gung Memorial Hospital, Keelung, Taiwan. 2 Division of Pediatric Pulmonology, Department of Pediatrics, Chang Gung Memorial
More informationControversial Issues in the Management of Childhood Asthma: Insights from NIH Asthma Network Studies
Controversial Issues in the Management of Childhood Asthma: Insights from NIH Asthma Network Studies Stanley J. Szefler, MD Helen Wohlberg and Herman Lambert Chair in Pharmacokinetics, Head, Pediatric
More informationExhaled Nitric Oxide Today s Asthma Biomarker. Richard F. Lavi, MD FAAAAI FAAP
Exhaled Nitric Oxide Today s Asthma Biomarker Richard F. Lavi, MD FAAAAI FAAP Objectives Describe exhaled nitric oxide physiology and pathophysiology Review the current literature regarding exhaled nitric
More informationInduced sputum to assess airway inflammation: a study of reproducibility
Clinical and Experimental Allergy. 1997. Volume 27. pages 1138-1144 Induced sputum to assess airway inflammation: a study of reproducibility A. SPANEVELLO, G. B. MIGLIORI. A. SHARARA*, L. BALLARDlNIt,
More informationDiagnosing Asthma Comparisons between Exhaled Nitric Oxide Measurements and Conventional Tests
Diagnosing Asthma Comparisons between Exhaled Nitric Oxide Measurements and Conventional Tests Andrew D. Smith, Jan O. Cowan, Sue Filsell, Chris McLachlan, Gabrielle Monti-Sheehan, Pamela Jackson, and
More informationClinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy
Clinical Implications of Asthma Phenotypes Michael Schatz, MD, MS Department of Allergy Definition of Phenotype The observable properties of an organism that are produced by the interaction of the genotype
More informationCOPYRIGHTED MATERIAL. Definition and Pathology CHAPTER 1. John Rees
CHAPTER 1 Definition and Pathology John Rees Sherman Education Centre, Guy s Hospital, London, UK OVERVIEW Asthma is an overall descriptive term but there are a number of more or less distinct phenotypes
More informationBaseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre
Eur Respir J 2; 5: 248±253 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2 European Respiratory Journal ISSN 93-936 Baseline airway hyperresponsiveness and its reversible component: role
More informationASTHMA. Epidemiology. Pathophysiology. Diagnosis. IAP UG Teaching slides
BRONCHIAL ASTHMA ASTHMA Epidemiology Pathophysiology Diagnosis 2 CHILDHOOD ASTHMA Childhood bronchial asthma is characterized by Airway obstruction which is reversible Airway inflammation Airway hyper
More informationMechanisms of action of bronchial provocation testing
Mechanisms of action of bronchial provocation testing TSANZ / ANZSRS Masterclass: April 3rd, 2016 13:00 13:30 John D. Brannan PhD Scientific Director - Dept. Respiratory & Sleep Medicine John Hunter Hospital,
More informationDefining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness
Defining Asthma: Clinical Criteria Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine, 2nd ed. Murray, Nadel, eds.(saunders:philadelphia)
More informationClinical Issues Research Implemented April 2010 Asthma Major Recommendations Goals of asthma: - 1) reduction of impairment freedom from symptoms,
Asthma Major Recommendations Goals of : - 1) reduction of impairment freedom from symptoms, such as cough, shortness of breath, wheezing, and disturbed sleep minimal need (< 2 times per week) of short
More informationPeriostin as a biomarker for the diagnosis of pediatric asthma
Pediatric Allergy and Immunology ORIGINAL ARTICLE Periostin as a biomarker for the diagnosis of pediatric asthma Asthma Takashi Inoue 1,2, Kenichi Akashi 1, Masako Watanabe 1, Yuichi Ikeda 3, Shuichi Ashizuka
More informationEvolution of asthma from childhood. Carlos Nunes Center of Allergy and Immunology of Algarve, PT
Evolution of asthma from childhood Carlos Nunes Center of Allergy and Immunology of Algarve, PT allergy@mail.telepac.pt Questionnaire data Symptoms occurring once or several times at follow-up (wheeze,
More informationMedicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air
Medicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air through the airways. As asthma, COPD ( chronic bronchitis
More informationThe FDA Critical Path Initiative
The FDA Critical Path Initiative Clinical Considerations for Demonstration of Dose-response for Inhaled Corticosteroids - Exhaled Nitric Oxide Model Badrul A. Chowdhury, MD, PhD Director Division of Pulmonary
More informationW heezing in infants and preschool children is
1053 PAEDIATRIC LUNG DISEASE The safety and quality of endobronchial biopsy in children under five years old S Saglani, D N R Payne, A G Nicholson, M Scallan, E Haxby, A Bush... See end of article for
More informationOn completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
More informationMEDICAL POLICY. Proprietary Information of YourCare Health Plan
MEDICAL POLICY PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationImmunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine
Immunology of Asthma Kenneth J. Goodrum,Ph Ph.D. Ohio University College of Osteopathic Medicine Outline! Consensus characteristics! Allergens:role in asthma! Immune/inflammatory basis! Genetic basis!
More informationAsthma Update A/Prof. John Abisheganaden. Senior Consultant, Dept Of Respiratory & Crit Care Medicine Tan Tock Seng Hospital
Asthma Update - 2013 A/Prof. John Abisheganaden Senior Consultant, Dept Of Respiratory & Crit Care Medicine Tan Tock Seng Hospital Asthma A complex syndrome Multifaceted disease Heterogeneous Genetic and
More informationExercise-Induced Bronchospasm. Michael A Lucia, MD, FCCP Asst Clinical Professor, UNR School of Medicine Sierra Pulmonary & Sleep Institute
Exercise-Induced Bronchospasm Michael A Lucia, MD, FCCP Asst Clinical Professor, UNR School of Medicine Sierra Pulmonary & Sleep Institute EIB Episodic bronchoconstriction with exercise May be an exacerbation
More informationSearching for Targets to Control Asthma
Searching for Targets to Control Asthma Timothy Craig Distinguished Educator Professor Medicine and Pediatrics Penn State University Hershey, PA, USA Inflammation and Remodeling in Asthma The most important
More informationAsthma Pathophysiology and Treatment. John R. Holcomb, M.D.
Asthma Pathophysiology and Treatment John R. Holcomb, M.D. Objectives Definition of Asthma Epidemiology and risk factors of Asthma Pathophysiology of Asthma Diagnostics test of Asthma Management of Asthma
More informationMonitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study
Eur Respir J 2010; 35: 48 53 DOI: 10.1183/09031936.00130008 CopyrightßERS Journals Ltd 2010 Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study J. Chakir*, L. Loubaki*,
More informationBorg scores before and after challenge with adenosine 5'-monophosphate and methacholine in subjects with COPD and asthma
Eur Respir J 2000; 16: 486±490 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2000 European Respiratory Journal ISSN 0903-1936 Borg scores before and after challenge with adenosine 5'-monophosphate
More informationL eukotrienes (LTs) C4,D4, and E4, known as cysteinyl(cys)-
465 ATHMA Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients PČáp, J Chládek, F Pehal, M Malý, V Petrů, P J Barnes, P Montuschi... ee end of article for authors
More informationOutline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?
Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado
More informationRespiratory Pharmacology PCTH 400 Asthma and β-agonists
Respiratory Pharmacology PCTH 400 Asthma and β-agonists Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Director, Centre of
More informationClinical significance of airway inflammation in bronchcial asthma. Comparison with chronic obstructive bronchiolitis.
24 Airway inflammation in asthma Clinical significance of airway inflammation in bronchcial asthma. Comparison with chronic obstructive bronchiolitis. Yoshiro Tanizaki, Hikaru Kitani, Takashi Mifune, Fumihiro
More informationRelationship between Methacholine Challenge Testing and exhaled Nitric Oxide in adult patients with suspected bronchial asthma
O R I G I N A L A R T I C L E S Eur Ann Allergy Clin Immunol Vol 46, N 3, 109-113, 2014 M. Giovannini, M. Valli, V. Ribuffo, R. Melara, G. Cappiello, E. Businarolo, A. Andreani Relationship between Methacholine
More informationMETHODS Study subjects
Airway cytokine expression measured by means of protein array in exhaled breath condensate: Correlation with physiologic properties in asthmatic patients Kazuto Matsunaga, MD, PhD, Satoru Yanagisawa, MD,
More informationExhaled Biomarkers Asthma & COPD. AS Paul DM Seminar 30 March 07
Exhaled Biomarkers Asthma & COPD AS Paul DM Seminar 30 March 07 Introduction Diagnosis and course of COPD/Asthma Clinical information Pulmonary function tests Arterial blood gases Chest X-raysX No direct
More informationAirways hyperresponsiveness to different inhaled combination therapies in adolescent asthmatics
Airways hyperresponsiveness to different inhaled combination therapies in adolescent asthmatics Daniel Machado 1, MD Celso Pereira 1,2, MD, PhD Beatriz Tavares 1, MD Graça Loureiro 1, MD António Segorbe-Luís
More informationBronchial asthma. E. Cserháti 1 st Department of Paediatrics. Lecture for english speaking students 5 February 2013
Bronchial asthma E. Cserháti 1 st Department of Paediatrics Lecture for english speaking students 5 February 2013 Epidemiology of childhood bronchial asthma Worldwide prevalence of 7-8 and 13-14 years
More informationThe Asthma Guidelines: Diagnosis and Assessment of Asthma
The Asthma Guidelines: Diagnosis and Assessment of Asthma Christopher H. Fanta, M.D. Partners Asthma Center Brigham and Women s Hospital Harvard Medical School Objectives Know how the diagnosis of asthma
More informationSystems Pharmacology Respiratory Pharmacology. Lecture series : General outline
Systems Pharmacology 3320 2017 Respiratory Pharmacology Associate Professor Peter Henry (Rm 1.34) Peter.Henry@uwa.edu.au Division of Pharmacology, School of Biomedical Sciences Lecture series : General
More informationKEY WORDS airflow limitation, airway hyperresponsiveness, airway inflammation, airway lability, peak expiratory flow rate
Allergology International. 2013;62:343-349 DOI: 10.2332 allergolint.13-oa-0543 ORIGINAL ARTICLE Stratifying a Risk for an Increased Variation of Airway Caliber among the Clinically Stable Asthma Atsushi
More informationMeeting the Challenges of Asthma
Presenter Disclosure Information 11:05 11:45am Meeting the Challenge of Asthma SPEAKER Christopher Fanta, MD The following relationships exist related to this presentation: Christopher Fanta, MD: No financial
More informationDR REBECCA THOMAS CONSULTANT RESPIRATORY PHYSICIAN YORK DISTRICT HOSPITAL
DR REBECCA THOMAS CONSULTANT RESPIRATORY PHYSICIAN YORK DISTRICT HOSPITAL Definition Guidelines contact complicated definitions Central to this is Presence of symptoms Variable airflow obstruction Diagnosis
More informationLeukotriene C 4 synthase polymorphisms and responsiveness to leukotriene antagonists in asthma
Blackwell Science, LtdOxford, UKBCPBritish Journal of Clinical Pharmacology0306-5251Blackwell Publishing 2003? 2003564422426Original ArticleLeukotriene C4 synthasej. J. Lima et al. Leukotriene C 4 synthase
More informationInhaled glucocorticoids (GCs) have revolutionized
Factors Influencing the Responsiveness to Inhaled Glucocorticoids of Patients With Moderate-to-Severe Asthma* An-Soo Jang, MD; June-Hyuk Lee, MD; Sung Woo Park, MD; Young Mok Lee, MD; Soo Taek Uh, MD;
More informationLuis Prieto, PhD; Laura Bruno, MD; Valentina Gutiérrez, PhD; Sonia Uixera, MD; Carmen Pérez-Francés, MD; Amparo Lanuza, PhD; and Ana Ferrer, MD
Airway Responsiveness to Adenosine 5 -Monophosphate and Exhaled Nitric Oxide Measurements* Predictive Value as Markers for Reducing the Dose of Inhaled Corticosteroids in Asthmatic Subjects Luis Prieto,
More informationRESPIRATORY CARE IN GENERAL PRACTICE
RESPIRATORY CARE IN GENERAL PRACTICE Definitions of Asthma and COPD Asthma is due to inflammation of the air passages in the lungs and affects the sensitivity of the nerve endings in the airways so they
More informationE-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling
E-1 Role of IgE and IgE receptors in allergic airway inflammation and remodeling Ruby Pawankar, MD, Ph.D. FRCP, FAAAAI Prof. Div of Allergy, Dept of Pediatrics Nippon Medical School Tokyo, Japan pawankar.ruby@gmail.com
More information2.6 MONITORING ASTHMA
2.6 MONITORING ASTHMA 2.6.1 MONITORING ASTHMA IN ADULTS In the majority of patients with asthma symptom-based monitoring is adequate. Patients achieving control of symptoms with treatment have a low risk
More informationLecture Notes. Chapter 3: Asthma
Lecture Notes Chapter 3: Asthma Objectives Define asthma and status asthmaticus List the potential causes of asthma attacks Describe the effect of asthma attacks on lung function List the clinical features
More informationD N R Payne, N M Wilson, A James, H Hablas, C Agrafioti, A Bush
Thorax 2001;56:345 350 345 Original articles Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK DNRPayne N M Wilson A James H Hablas C Agrafioti A
More informationAir Flow Limitation. In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation.
Asthma Air Flow Limitation In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation. True whether reversible, asthma and exercise-induced bronchospasm,
More informationPulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?
Pulmonary Function Testing: Concepts and Clinical Applications David M Systrom, MD Potential Conflict Of Interest Nothing to disclose pertinent to this presentation BRIGHAM AND WOMEN S HOSPITAL Harvard
More informationNON-SPECIFIC BRONCHIAL HYPERESPONSIVENESS. J. Sastre. Allergy Service
NON-SPECIFIC BRONCHIAL HYPERESPONSIVENESS J. Sastre. Allergy Service Asthma: definition Asthma is a syndrome defined on basis of three main aspects: 1- Symptoms due to variable and reversible airway obstruction
More informationAsthma Upate 2018: What s New Since the 2007 Asthma Guidelines of NAEPP?
10:50-11:50am Asthma Update 2018: What s New Since the 2007 National Asthma Guidelines? SPEAKER Christopher H. Fanta, MD Disclosures The following relationships exist related to this presentation: Christopher
More informationExhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children
Eur Respir J 1999; 13: 1386±1390 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 1999 European Respiratory Journal ISSN 0903-1936 Exhaled nitric oxide and sputum eosinophil markers of inflammation
More informationAlternative agents for anti-inflammatory treatment of asthma
Alternative agents for anti-inflammatory treatment of asthma Stanley J. Szefler, MD, a,b and Harold S. Nelson, MD, c Denver, Colo Recent guidelines for the management of asthma have emphasized the role
More informationAsthma Phenotypes, Heterogeneity and Severity: The Basis of Asthma Management
Asthma Phenotypes, Heterogeneity and Severity: The Basis of Asthma Management Eugene R. Bleecker, MD Professor and Director, Center for Genomics & Personalized Medicine Research Professor, Translational
More informationDiagnosis, Treatment and Management of Asthma
Diagnosis, Treatment and Management of Asthma Asthma is a complex disorder characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation.
More informationDaily ambulatory exhaled nitric oxide measurements in asthma
Pediatr Allergy Immunol 2006: 17: 189 193 DOI: 10.1111/j.1399-3038.2006.00394.x Ó 2006 The Authors Journal compilation Ó 2006 Blackwell Munksgaard PEDIATRIC ALLERGY AND IMMUNOLOGY Daily ambulatory exhaled
More informationRole of Leukotriene Receptor Antagonists in the Treatment of Exercise-Induced Bronchoconstriction: A Review
Review Article Role of Leukotriene Receptor Antagonists in the Treatment of Exercise-Induced Bronchoconstriction: A Review George S. Philteos, MD, FRCP(C); Beth E. Davis, BSc; Donald W. Cockcroft, MD,
More informationDual-Controller Asthma Therapy: Rationale and Clinical Benefits
B/1 Dual-Controller Asthma Therapy: Rationale and Clinical Benefits MODULE B The 1997 National Heart, Lung, and Blood Institute (NHLBI) Expert Panel guidelines on asthma management recommend a 4-step approach
More informationAmanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ
Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ Financial Disclosures Advanced Practiced Advisory Board for Circassia Learning Objectives 1. Briefly
More informationAsthma. Don Hayes, Jr., MD, FAAP, FACP
Asthma Don Hayes, Jr., MD, FAAP, FACP Director, University of Kentucky Asthma Center Kentucky Children s Hospital & Assistant Professor of Pediatrics & Internal Medicine University of Kentucky College
More information7/7/2015. Somboon Chansakulporn, MD. History of variable respiratory symptoms. 1. Documented excessive variability in PFT ( 1 test)
Definition of Asthma GINA 2010: Chronic inflammatory disorder of the airways Airway hyper-responsiveness Recurrent wheezing, breathlessness, chest tightness, coughing Variable, reversible airflow obstruction
More informationIdentifying Biologic Targets to Attenuate or Eliminate Asthma Exacerbations
Identifying Biologic Targets to Attenuate or Eliminate Exacerbations exacerbations are a major cause of disease morbidity and costs. For both children and adults, viral respiratory infections are the major
More informationResearch Article Subjects in a Population Study with High Levels of FENO Have Associated Eosinophil Airway Inflammation
International Scholarly Research Network ISRN Allergy Volume 2011, Article ID 792613, 6 pages doi:10.5402/2011/792613 Research Article Subjects in a Population Study with High Levels of Have Associated
More informationSupplementary Medications during asthma attack. Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus
Supplementary Medications during asthma attack Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus Conflicts of Interest None Definition of Asthma Airway narrowing that is
More informationMEDICAL POLICY. Proprietary Information of Excellus Health Plan, Inc. A nonprofit independent licensee of the BlueCross BlueShield Association
MEDICAL POLICY SUBJECT: MEASUREMENT OF EXHALED MARKERS OF AIRWAY INFLAMMATION IN PATIENTS WITH ASTHMA POLICY NUMBER: 2.01.41 CATEGORY: Technology Assessment EFFECTIVE DATE: 04/15/04 REVISED DATE: 02/17/05,
More informationPersonalized medicine in childhood asthma. Dr Mariëlle Pijnenburg, Erasmus MC Sophia, Rotterdam, NL
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS for your personal use only, as submitted by the author.
More informationTREAMENT OF RECURRENT VIRUS-INDUCED WHEEZING IN YOUNG CHILDREN. Dr Lại Lê Hưng Respiratory Department
TREAMENT OF RECURRENT VIRUS-INDUCED WHEEZING IN YOUNG CHILDREN Dr Lại Lê Hưng Respiratory Department Literature review current through: Feb 2013. This topic last updated: Aug 14, 2012 INTRODUCTION Wheezing
More informationBronchial hyperresponsiveness in asthmatic adults A long-term correlation study
European Review for Medical and Pharmacological Sciences 2005; 9: 125-131 Bronchial hyperresponsiveness in asthmatic adults A long-term correlation study R. CARBONE, F. LUPPI *, A. MONSELISE **, G. BOTTINO
More informationRESPIRATORY BLOCK. Bronchial Asthma. Dr. Maha Arafah Department of Pathology KSU
RESPIRATORY BLOCK Bronchial Asthma Dr. Maha Arafah Department of Pathology KSU marafah@ksu.edu.sa Jan 2018 Objectives Define asthma (BA) Know the two types of asthma 1. Extrinsic or atopic allergic 2.
More information